Nasdaq Rises Over 100 Points; Delta Air Lines Posts Upbeat Results
Portfolio Pulse from Lisa Levin
U.S. stocks traded higher with the Nasdaq Composite gaining over 100 points. Delta Air Lines reported better-than-expected Q2 results with a 19% YoY adjusted operating revenue growth to $14.61 billion, beating the consensus of $14.46 billion. Shares of Jiuzi Holdings, Synaptogenix, and 60 Degrees Pharmaceuticals rose significantly. However, Viasat, Cryoport, and First Wave BioPharma shares dropped due to various reasons.
July 13, 2023 | 4:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Delta Air Lines reported better-than-expected Q2 results, beating the consensus.
Delta's better-than-expected Q2 results are likely to boost investor confidence and drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Jiuzi Holdings shares shot up 59%.
The significant rise in Jiuzi Holdings shares indicates positive investor sentiment, which could drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Shares of Synaptogenix got a boost, shooting 51% up.
The significant rise in Synaptogenix shares indicates positive investor sentiment, which could drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
60 Degrees Pharmaceuticals shares were up, gaining 31%.
The significant rise in 60 Degrees Pharmaceuticals shares indicates positive investor sentiment, which could drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Cryoport shares were down 27% after the company announced lower than expected interim Q2 earnings.
Cryoport's lower than expected Q2 earnings could negatively impact investor confidence and drive the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
First Wave BioPharma shares fell 33% after the company said preliminary data from Phase 2 SPAN trial indicate that it is likely the primary efficacy endpoint was not achieved.
The disappointing trial data from First Wave BioPharma could negatively impact investor confidence and drive the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Viasat shares dropped 29% after the company reported an unexpected event that may impact satellite performance.
The unexpected event reported by Viasat could negatively impact investor confidence and drive the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100